Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alina Depardon
Institutions:
Friedrich-Alexander-Universität Erlangen-Nürnberg,
Universitätsklinikum Erlangen
Observed institutions:
Friedrich-Alexander-Universität Erlangen-Nürnberg,
Universitätsklinikum Erlangen,
Comprehensive Cancer Center Erlangen
ORCID:
0009-0002-8974-1704
Observed ORCID:
0009-0002-8974-1704
OpenAlex ID:
A5099521654
Fine-tuning a local LLaMA-3 large language model for automated privacy-preserving physician letter generation in radiation oncology
2025
·
Yihao Hou
, Christoph Bert
, et al.
·
Frontiers in Artificial Intelligence
·
44
PDF
Short-course radiotherapy versus long-course chemoradiotherapy in total neoadjuvant therapy of rectal cancer – A multicenter analysis of early outcomes and toxicity
2025
·
Georg Wurschi
, Miriam Kesselmeier
, et al.
·
Radiotherapy and Oncology
·
7
PDF
Balancing barriers: Family, career, and gender equality in radiation oncology and radiation research—An interdisciplinary prospective survey among the young workforce
2025
·
Maike Trommer
, Maximilian Grohmann
, et al.
·
Strahlentherapie und Onkologie
·
6
PDF
Quality of life following total neoadjuvant therapy for rectal cancer
2025
·
Georg W. Wurschi
, Markus Diefenhardt
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
5
PDF
TNTox – Outcome und Toxizität nach totaler neoadjuvanter Therapie beim Rektumkarzinom: Eine multizentrische Analyse der jDEGRO Trial Group
2024
·
Georg Wurschi
, Matthias Mäurer
, et al.
·
Forum
·
3
Clinical and treatment-related predictors of complete response after total neoadjuvant therapy for rectal cancer in a large multicenter analysis
2026
·
Georg W. Wurschi
, Melanie Schneider
, et al.
·
Clinical and Translational Radiation Oncology
·
1
PDF
1739 Automatic but interactive: A real-world evaluation of promptable AI auto-segmentation for GTV delineation (PROMPTO)
2026
·
Daniel Höfler
, Philipp Schubert
, et al.
·
Radiotherapy and Oncology
1786 Sex-specific differences in outcomes and toxicity after total neoadjuvant therapy for locally advanced rectal cancer
2026
·
Maike Trommer
, Melanie Schneider
, et al.
·
Radiotherapy and Oncology
Oxaliplatin‐induced neuropathy after total neoadjuvant therapy for rectal cancer: Dose–response relationship and impact on quality of life
2026
·
Georg W. Wurschi
, Andreas Hinz
, et al.
·
International Journal of Cancer
PDF
2229 Dose-effect relationship on response rates and toxicity in total neoadjuvant therapy for locally advanced rectal cancer – A multicenter analysis
2025
·
Georg W. Wurschi
, Miriam Kesselmeier
, et al.
·
Radiotherapy and Oncology
2182 Short-course radiotherapy versus chemoradiotherapy in total neoadjuvant therapy of rectal cancer – A multicenter analysis of outcomes and toxicity
2025
·
Georg W. Wurschi
, Miriam Kesselmeier
, et al.
·
Radiotherapy and Oncology
Show more works
View as search
Works count:
11
Citation count:
66
H-index:
4
I10-index:
1
Year
Topic
Type